Author Search Results

Moussa B. H. Youdim

Moussa B. H. Youdim (born, February 28, 1940) is an Israeli neuroscientist specializing in neurochemistry and neuropharmacology. He is the discoverer of both monoamine oxidase (MAO) B inhibitors l-deprenyl (Selegiline) and rasagiline (Azilect) as anti-Parkinson drugs which possess neuroprotective activities. He is currently professor emeritus at Technion - Faculty of Medicine and President of Youdim Pharmaceuticals. Provided by Wikipedia

1

Correction for the article “Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?” by Moussa B. H. Youdim

by Moussa B.H. Youdim
Published 2015-10-01

Get full text

Article
2

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?

by Moussa B.H. Youdim
Published 2010-10-01

Get full text

Article
3

Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism

by Yotam Sagi, Silvia Mandel, Tamar Amit, Moussa B.H. Youdim
Published 2007-01-01

Get full text

Article
4

Neuroprotection and Neuroregeneration in Alzheimer's Disease

by Kiminobu Sugaya, Moussa B. H. Youdim, Agneta Nordberg, K. S. Jagannatha Rao
Published 2012-01-01

Get full text

Article
5

Monoamine oxidase A upregulated by chronic intermittent hypoxia activates indoleamine 2,3-dioxygenase and neurodegeneration.

by Chun-Sing Lam, Jing-Jie Li, George Lim Tipoe, Moussa B H Youdim, Man-Lung Fung
Published 2017-01-01

Get full text

Article
6

A Novel Antioxidant Multitarget Iron Chelator M30 Protects Hepatocytes against Ethanol-Induced Injury

by Jia Xiao, Yi Lv, Bin Lin, George L. Tipoe, Moussa B. H. Youdim, Feiyue Xing, Yingxia Liu
Published 2015-01-01

Get full text

Article
7

M30 Antagonizes Indoleamine 2,3-Dioxygenase Activation and Neurodegeneration Induced by Corticosterone in the Hippocampus.

by Chun-Sing Lam, George Lim Tipoe, Johnny Kong-Ching Wong, Moussa B H Youdim, Man-Lung Fung
Published 2016-01-01

Get full text

Article
8

Correction: I1 Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline

by Yaron D. Barac, Orit Bar-Am, Esti Liani, Tamar Amit, Luba Frolov, Elena Ovcharenko, Itzchak Angel, Moussa B. H. Youdim, Ofer Binah
Published 2013-01-01

Get full text

Article
9

I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline.

by Yaron D Barac, Orit Bar-Am, Esti Liani, Tamar Amit, Luba Frolov, Elena Ovcharenko, Itzchak Angel, Moussa B H Youdim, Ofer Binah
Published 2012-01-01

Get full text

Article
10

Correction: I Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline.

by Yaron D. Barac, Orit Bar-Am, Esti Liani, Tamar Amit, Luba Frolov, Elena Ovcharenko, Itzchak Angel, Moussa B. H. Youdim, Ofer Binah
Published 2013-01-01

Get full text

Article
11

Multi-target directed donepezil-like ligands for Alzheimer's disease

by Mercedes eUnzeta, Gerard eEsteban, Irene eBolea, Wieslawa Agnieszka Fogel, RONA R. RAMSAY, Moussa B.H. Youdim, Keith F Tipton, Jose eMarco-Contelles
Published 2016-05-01

Get full text

Article